Tag: Europe
-
Start-up Funds Univ. Medical Cannabis Research
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London.
-
Genetic Acids Harnessed to Promote Wound Healing
A bioengineering team designed a way to use acids in DNA that in lab tests promote wound repair by encouraging production of healing proteins in surrounding tissues.
-
Trial Testing Breath Detection for Cancer
A clinical trial is recruiting participants to test a technology that analyzes exhaled breath for indicators of specific types of cancer.
-
Infographic – London Tops Favorite European Workplaces
Brexit, shmexit. A recent study from labor market research company Intelligence Group shows London is the most desired place to work for Europeans today.
-
Eye Drops Reverse Infected Eye Scarring
Eye drops containing a therapeutic protein and applied as a gel, are shown in lab mice to remove scar tissue from the surface of infected or damaged corneas.
-
Companies to Analyze 40,000 Protein Samples
A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples.
-
Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal
Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain.
-
Companies Partner on High-Resolution 3-D Tissue Printer
Two developers of tissue engineering technologies are building a three-dimensional bioprinter that produces high resolution, finely structured human tissue, including tiny blood vessels.
-
Self-Powered Sun Exposure Chip, App Developed
A tiny wireless sensor chip measuring exposure to ultraviolet or UV rays from the sun, developed by a university lab, is now offered by a cosmetics company with an accompanying smartphone app.
-
Janssen Licensing Cancer Antibodies in $1.8B Deal
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas.